Treatment Approach in Stage III NSCLC

 

Treatment Approach in Stage III NSCLC
09:40

John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

  • 1,818 views
  • March 8, 2023
  • 6
10:51

Winship Cancer Institute - Emory University

Optimising Chemoradiation to Reduce Pneumonitis Risk in Patients With Locally Advanced NSCLC

FEATURING Neal McCall
  • 166 views
  • March 1, 2023
  • 2
10:47

Giulia Pasello

The Multidisciplinary Approach in Stage III NSCLC Over 10 Years: From RT Optimisation to Innovative Systemic Treatments

  • 127 views
  • March 20, 2023
  • 1
12:40

Yale Cancer Center

Consolidation IO Following CRT in Stage III NSCLC

FEATURING Henry Park
  • 247 views
  • March 17, 2023
  • 2
15:01

OncoAlert

Radiation Oncology 2022: Advances in NSCLC

FEATURING Henning Willers, Amy Wisdom
  • 319 views
  • February 15, 2023
  • 1
09:13

Federico Cappuzzo

New Options in Stage III NSCLC

  • 220 views
  • November 10, 2022
  • 4
12:41

Lung Cancer Europe (LuCE)

Unresectable Stage III NSCLC: Key Findings

FEATURING Jarushka Naidoo
  • 290 views
  • July 26, 2022
  • 1
14:23

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Updates on the Use of Consolidation IO in NSCLC Based on Biomarker Selection

FEATURING Everett Vokes
  • 96 views
  • March 16, 2023
41:16

Total Health

2023 Case-Based Clinical Updates in Lung Cancer

FEATURING Nagashree Seetharamu
  • 812 views
  • March 16, 2023
  • 8
22:46

2023 Texas Lung Cancer Conference Coverage

When Is PD(L)1 Monotherapy for NSCLC Enough?

FEATURING Shirish Gadgeel
  • 40 views
  • June 5, 2023
23:36

CHEST 2022 Coverage

Immune Checkpoint Inhibitor Pneumonitis in Lung Cancer

FEATURING Jennifer Possick
  • 1,482 views
  • December 20, 2022
  • 11
19:41

Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

  • 1,879 views
  • December 13, 2022
  • 10
13:19

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced NSCLC

FEATURING Estelamari Rodriguez
  • 2,023 views
  • March 13, 2023
  • 12
37:21

Moffitt Cancer Center

Managing Immunotherapy-Related Adverse Events

FEATURING Kaitlin Hendrix, Sarah Logan
  • 306 views
  • April 4, 2023
  • 1
17:57

2023 Texas Lung Cancer Conference Coverage

Advantages of Chemoimmunotherapy for NSCLC

FEATURING Melissa Johnson
  • 127 views
  • April 14, 2023
  • 3
07:58

Janeesh Sekkath Veedu

Survival Outcomes of Surgery-Based Treatment or Definitive CRT With IO Consolidation in Stage IIIA NSCLC in the IO Era: NCDB Analysis

  • 129 views
  • April 21, 2023
  • 1
20:34

2023 Texas Lung Cancer Conference Coverage

Current Role of Adjuvant IO in NSCLC

FEATURING Jessica Donington
  • 95 views
  • April 14, 2023
  • 3
16:36

Fox Chase Cancer Center

Adjuvant Therapy for Resectable NSCLC: State of the Art

FEATURING Martin Edelman
  • 84 views
  • April 28, 2023
  • 1
08:55

Insights from 2023 ASCO® Annual Meeting

Surgical Aspects in the Treatment of Locally Advanced NSCLC

FEATURING Giulia Veronesi
  • 464 views
  • June 5, 2023
  • 2
08:05

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ARC-7: Randomized Phase 2 Study of Domvanalimab + Zimberelimab ± Etrumadenant vs. Zimberelimab in 1L PD-L1-High mNSCLC"

FEATURING Melissa Johnson
  • 819 views
  • June 9, 2023
  • 5